Locoregional Treatment of Glioblastoma With Targeted αlpha Therapy
[213Bi]Bi-DOTA–Substance P Versus [225Ac]Ac-DOTA–Substance P—Analysis of Influence Parameters
Glioblastoma (GB) is the most malignant primary brain tumor. Therefore, introduction of newtreatment options is critically important. The aim of this study was to assess local treatment with α emitters [213Bi]Bi- DOTA–substance P (SP) and [225Ac]Ac-DOTA-SP.
KROLICKI Leszek;
KUNIKOWSKA Jolanta;
BRUCHERTSEIFER Frank;
KULINSKI Radoslaw;
PAWLAK Dariusz;
KOZIARA H;
ROLA R;
MORGENSTERN Alfred;
MERLO A.;
2023-10-12
LIPPINCOTT WILLIAMS & WILKINS
JRC134533
0363-9762 (online),
https://journals.lww.com/nuclearmed/Abstract/2023/05000/Locoregional_Treatment_of_Glioblastoma_With.2.aspx,
https://publications.jrc.ec.europa.eu/repository/handle/JRC134533,
10.1097/RLU.0000000000004608 (online),
Additional supporting files
| File name | Description | File type | |
|---|
